NCT04850417View on ClinicalTrials.gov

Randomized Study of Beta-Blockers and Antiplatelets in Patients With Spontaneous Coronary Artery Dissection

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

April 30, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2028

Conditions
Spontaneous Coronary Artery Dissection
Interventions
DRUG

Beta blocker, aspirin, clopidogrel

Pragmatic design. Beta-blockers and Antiplatelets drugs selected by the investigators. Asprin and Clopidogrel recomended for patients allocated to prologed DAPT. Aspirin Alone recomended for patients allocated to short antiplatelet therapy

All Listed Sponsors
collaborator

Instituto de Investigación Sanitaria Hospital Universitario de la Princesa

OTHER

collaborator

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

OTHER

lead

Spanish Society of Cardiology

OTHER